Passions

Skiing

Traveling

Mountain biking

Sky diving

Golf

Experience

CalypsoAI to Be Acquired by F5

September 17, 2025

Cooley advised CalypsoAI, an adaptive artificial intelligence security platform that empowers enterprises to innovate safely, on its acquisition by F5, a global leader in delivering and securing every app and application programming interface.

Read more

Related contacts

Jon Gavenman
Partner, Palo Alto
Sepideh Mousakhani
Partner, Palo Alto
Kealan Santistevan
Associate, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Caitlin Courtney
Partner, Palo Alto
Jeff Goldman
Special Counsel, Palo Alto
Alex Maki
Associate, Palo Alto
Sophie Bucci
Associate, Santa Monica
Calvin Lee
Associate, New York
David Fletcher
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Bill Galliani
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Linch
Special Counsel, London
MaryBeth Shreiner
Special Counsel, Reston
Karen Tsai
Special Counsel, Washington, DC
Umer Chaudhry
Associate, Washington, DC
Tucker Cochenour
Associate, Palo Alto
Mark Cornillez-Ty
Associate, Los Angeles
Mari Dugas
Associate, Washington, DC
Joshua Elefant
Associate, Palo Alto
Rick Jantz
Associate, Santa Monica
Emily Mok
Associate, Reston
Michelle Peleg
Associate, San Francisco
Anna Anderson
Paralegal Specialist, London
Patrick O. Johnson
Associate, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Dualitas Therapeutics Launches With $65 Million Series A

September 16, 2025

Cooley advised Dualitas, a biotechnology company pioneering next-generation bispecific antibody therapies for immunology and inflammation, on its $65 million Series A financing, to advance a portfolio of next-generation bispecific antibodies, including lead programs DTX-103 in allergic disease and DTX-102 for autoimmune disease, and to accelerate the development of Dualitas’ proprietary DualScreen BsAb discovery engine.

Read more

Related contacts

Sara Semnani
Partner, Santa Monica
Noel Ripberger-Scheick
Associate, Palo Alto
Sam Thompson
Associate, Santa Monica
Michael Aridi Barake
Associate, Santa Monica
Cameron Hajialiakbar
Associate, Santa Monica
Christy Fairlie
Paralegal Specialist, Reston
Jake Ironfield
Transactional Quantitative Analyst, New York
Dillon Martinson
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
John Sellers
Senior Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kelley Harrington
Associate, Chicago
Shelby Saunders
Associate, New York

Related Practices & Industries

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]

July 25, 2025

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, Washington, DC
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Lovable Secures $200 Million Series A

July 17, 2025

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Karem M. Jarada
Associate, San Francisco
Carl Min
Associate, San Francisco
Chu Lee
Paralegal Specialist, San Francisco
Megan Browdie
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Julia R. Brinton
Special Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Education

West Virginia University, John Chambers College of Business and Economics
BS, Business Administration (Finance focus), summa cum laude, 2019

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.